Aptevo Therapeutics Inc

(NASDAQ:APVO)

Latest On Aptevo Therapeutics Inc (APVO):

Date/Time Type Description Signal Details
2023-05-11 16:38 ESTNewsAptevo Therapeutics GAAP EPS of $0.26 beats by $1.45N/A
2023-03-31 01:06 ESTNewsAptevo Therapeutics raises $9.6M in non-dilutive fundingN/A
2023-03-31 01:06 ESTNewsAptevo Therapeutics GAAP EPS of $1.57 beats by $0.64, revenue of $3.11M in-lineN/A
2022-12-13 02:36 ESTNewsAptevo shares more than double in value on phase 1 data for its leukemia drug candidateN/A
2022-11-10 12:58 ESTNewsAptevo Therapeutics GAAP EPS of -$1.50 beats by $0.14N/A
2022-09-19 18:56 ESTNewsAptevo Therapeutics receives approval to begin human trial of solid tumor therapyN/A
2022-08-11 22:52 ESTNewsAptevo Therapeutics GAAP EPS of $5.58N/A
2022-06-10 11:36 ESTNewsAptevo gains after disclosing additional remission data in leukemia trialN/A
2022-05-12 12:44 ESTNewsAptevo Therapeutics GAAP EPS of -$1.59 misses by $0.66, revenue of $3.11M misses by $0.64MN/A
2022-03-25 13:36 ESTNewsAptevo Therapeutics GAAP EPS of -$6.07 beats by $0.07, revenue of $12.29M beats by $0.26MN/A
2022-03-25 13:35 ESTNewsAptevo climbs as 2021 revenue more than doublesN/A
2022-02-10 03:32 ESTNewsAptevo Therapeutics receives $10M in non-dilutive milestone payment on RUXIENCE salesN/A
2022-01-21 23:22 ESTNewsAptevo Therapeutics Board Chairman Fuad El-Hibri to retireN/A
2021-11-24 14:05 ESTNewsWarning: APVO is at high risk of performing badlyN/A
2021-11-23 17:08 ESTNewsAptevo stock nearly doubles after APVO436 + chemotherapy resulted in complete remission in AMLN/A
2021-11-12 16:45 ESTNewsAptevo Therapeutics EPS beats by $0.03, misses on revenueN/A
2021-10-26 12:02 ESTNewsAptevo reports research on APVO436 for cytokine release syndrome in cancer patientsN/A
2021-08-17 08:44 ESTNewsAptevo reports APVO436 monotherapy results in blood cancers in oncology journalN/A
2021-08-12 12:18 ESTNewsAptevo Therapeutics EPS beats by $0.06, beats on revenueN/A
2021-07-20 19:21 ESTNewsAptevo meets primary endpoint in early-stage trial for blood cancer therapyN/A
2021-07-20 19:19 ESTNewsAptevo initiates expansion phase of APVO436 acute myeloid leukemia studyN/A
2021-07-20 18:58 ESTNewsAptevo Therapeutics added to the Russell Microcap IndexN/A
2021-03-31 16:42 ESTNewsAptevo Therapeutics EPS misses by $0.66, beats on revenueN/A
2021-03-24 14:09 ESTNewsAn Assessment On Aptevo TherapeuticsN/A
2020-12-13 03:12 ESTFinancialsCompany financials have been released.Neutral
2020-12-02 15:54 ESTNewsAptevo +7%, expands bispecific platform technology and introduces new bispecific prostate cancer candidateN/A
2020-12-02 15:53 ESTNewsAptevo: Positive Early Stage Data Makes This Highly InterestingN/A
2020-11-19 10:40 ESTNewsAptevo gets $50/share takeout offer from shareholder TangN/A
2020-11-17 03:08 ESTAnalyst RatingThe Analyst Target Price has increased from $53.33 to $65.67.Buy
2020-11-16 03:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 03:11 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:11 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 12:09 ESTNewsAptevo Therapeutics EPS misses by $0.10, beats on revenueN/A
2020-11-11 03:08 ESTEarnings EstimateAn EPS average of -$1.47 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-10 19:11 ESTAnalyst RatingThe Analyst Target Price has increased from $35 to $53.33.Buy
2020-11-10 06:19 ESTNewsAptevo Therapeutics rallies 113% as Tang Capital discloses 54% stakeN/A
2020-11-10 06:18 ESTNewsAptevo's lead drug achieves second remission in early-stage blood cancer studyN/A
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 2,650 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 107,901 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 29,682 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 34,044 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 8,482 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 137,241 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 171,626 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 71,241 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 77,133 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 160,000 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 160,000 shares indirectly via LP.Buy
2020-11-06 17:16 ESTInsider TradeKEVIN C TANG has acquired 60,146 shares indirectly via LP.Buy

About Aptevo Therapeutics Inc (APVO):

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics in the United States. Its marketed product includes IXINITY, a coagulation factor IX therapeutic indicated in adults and children 12 years of age and older with hemophilia B for control and prevention of bleeding episodes, and management of bleeding during operations. Its lead clinical candidate is APVO436, a bispecific immunotherapeutic protein that is in Phase 1/1b clinical trial for acute myeloid leukemia and high-grade myelodysplastic syndrome. The company's preclinical candidates include ALG.APV-527, a bispecific antibody to target 4-1BB x 5T4; APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40; and other pre-clinical development stage therapeutics focused on immuno-oncology. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

APVO Quotes by TradingView

See Advanced Chart

General

  • Name Aptevo Therapeutics Inc
  • Symbol APVO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 80
  • Last Split Factor1:14
  • Last Split Date2020-03-27
  • Fiscal Year EndDecember
  • IPO Date2016-07-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://aptevotherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.5
  • Price/Book (Most Recent Quarter) 73.91
  • Enterprise Value Revenue 5.05
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$2.07
  • Profit Margin -55%
  • Operating Margin -88%
  • Return on Assets -39%
  • Return on Equity -317%
  • Revenue 34.36 million
  • Earnings Per Share -$1.76
  • Revenue Per Share $10.62
  • Gross Profit -17260000
  • Quarterly Earnings Growth -93.6%
View More

Highlights

  • Market Capitalization 151.11 million
  • EBITDA -47696000
  • Analyst Target Price $65.67
  • Book Value Per Share $0.68
View More

Share Statistics

  • Shares Outstanding 4.38 million
  • Shares Float 1.73 million
  • % Held by Insiders 593%
  • % Held by Institutions 75.18%
  • Shares Short 200473
  • Shares Short Prior Month 165682
  • Short Ratio 2.84
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 7.44
  • 52 Week High $60
  • 52 Week Low $3.05
  • 50 Day Moving Average 35.13
  • 200 Day Moving Average 27.2
View More

Dividends

  • Dividend Date 2020-03-27
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aptevo Therapeutics Inc (APVO) Dividend Calendar:

APVO's last dividend payment was made to shareholders on March 27, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aptevo Therapeutics Inc (APVO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-10$1.46 million-$2.10-$2.01-4.48%
2020-06-302020-08-14$N/A-$2.10-$2.06-1.94%
2020-03-312020-05-13$N/A$0.89-$2.29138.86%
2019-12-312020-03-25$9.03 million-$1.26-$3.5964.93%
2019-09-302019-11-07$9.01 million-$2.24-$3.3633.33%
2019-06-302019-08-09$7.36 million-$4.20-$3.57-17.65%
2019-03-312019-05-09$7.02 million-$6.16-$6.160%
2018-12-312019-03-18$6.35 million-$8.68-$7.47-16.25%
2018-09-302018-11-14$5.82 million-$7.84-$8.032.33%
2018-06-302018-08-09$6.83 million-$8.12-$9.0310.08%
2018-03-312018-05-10$4.07 million-$8.82-$7.77-13.51%
2017-12-312018-03-13$2.82 million-$6.44-$4.48-43.75%
2017-09-302017-11-09$2.47 million$24.50$31.50-22.22%
2017-06-302017-08-10$3.53 million-$7.42-$8.5413.11%
2017-03-312017-05-12$2.14 million-$8.74-$9.9412.11%
2016-12-312017-03-31$2.78 million-$5.64-$6.168.41%
2016-09-302016-11-14$2.82 million-$11.10-$8.96-23.84%

Aptevo Therapeutics Inc (APVO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aptevo Therapeutics Inc (APVO) Chart:

Aptevo Therapeutics Inc (APVO) News:

Below you will find a list of latest news for Aptevo Therapeutics Inc (APVO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aptevo Therapeutics Inc (APVO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest APVO Trades:

Date Shares Price
Jun 13, 2022 2:25 PM EST439$3.69
Jun 13, 2022 3:06 PM EST100$3.68
Jun 13, 2022 3:49 PM EST100$3.64
Jun 13, 2022 7:01 PM EST100$3.5
Jun 13, 2022 7:58 PM EST100$3.53

Aptevo Therapeutics Inc (APVO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-29SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1671584/000119312520182311/0001193125-20-182311-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1671584/000000000019001761/0000000000-19-001761-index.htm
2019-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000089914019000297/0000899140-19-000297-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000089914020000170/0000899140-20-000170-index.htm
2019-03-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000091957419002515/0000919574-19-002515-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000091957420001646/0000919574-20-001646-index.htm
2019-03-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000093583619000170/0000935836-19-000170-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000093583620000108/0000935836-20-000108-index.htm
2018-08-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905618000952/0001019056-18-000952-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905618000956/0001019056-18-000956-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905618001110/0001019056-18-001110-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905618001118/0001019056-18-001118-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/0001019056-19-000174-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000176/0001019056-19-000176-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/0001019056-19-000178-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000180/0001019056-19-000180-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000182/0001019056-19-000182-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/0001019056-19-000184-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000186/0001019056-19-000186-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000291/0001019056-19-000291-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000402/0001019056-19-000402-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000476/0001019056-19-000476-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000487/0001019056-19-000487-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000610/0001019056-19-000610-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000612/0001019056-19-000612-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000614/0001019056-19-000614-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000616/0001019056-19-000616-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000618/0001019056-19-000618-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905619000620/0001019056-19-000620-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000239/0001019056-20-000239-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000240/0001019056-20-000240-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000241/0001019056-20-000241-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000242/0001019056-20-000242-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000243/0001019056-20-000243-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000244/0001019056-20-000244-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/0001019056-20-000433-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000436/0001019056-20-000436-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000437/0001019056-20-000437-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000438/0001019056-20-000438-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000439/0001019056-20-000439-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000440/0001019056-20-000440-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000441/0001019056-20-000441-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000451/0001019056-20-000451-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/0001019056-20-000452-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/0001019056-20-000454-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000101905620000463/0001019056-20-000463-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000103738919000008/0001037389-19-000008-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000103738920000144/0001037389-20-000144-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000114420419006624/0001144204-19-006624-index.htm
2019-01-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1671584/000119312519000762/0001193125-19-000762-index.htm
2019-02-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1671584/000119312519034145/0001193125-19-034145-index.htm
2019-02-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1671584/000119312519038218/0001193125-19-038218-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1671584/000119312519065760/0001193125-19-065760-index.htm
2019-03-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1671584/000119312519067852/0001193125-19-067852-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519070196/0001193125-19-070196-index.htm
2019-03-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519083529/0001193125-19-083529-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519150764/0001193125-19-150764-index.htm
2019-08-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1671584/000119312519218511/0001193125-19-218511-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519261704/0001193125-19-261704-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519268527/0001193125-19-268527-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519274983/0001193125-19-274983-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312519283425/0001193125-19-283425-index.htm
2020-01-31PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1671584/000119312520021667/0001193125-20-021667-index.htm
2020-02-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1671584/000119312520031518/0001193125-20-031518-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312520059183/0001193125-20-059183-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312520071893/0001193125-20-071893-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312520087225/0001193125-20-087225-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312520178467/0001193125-20-178467-index.htm
2020-06-29SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1671584/000119312520182311/0001193125-20-182311-index.htm
2020-07-13SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1671584/000119312520191863/0001193125-20-191863-index.htm
2020-07-29SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1671584/000119312520202536/0001193125-20-202536-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000119312520286121/0001193125-20-286121-index.htm
2020-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000120919120057303/0001209191-20-057303-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-06SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1671584/000121465920009221/0001214659-20-009221-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000125889719001030/0001258897-19-001030-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000125889720000784/0001258897-20-000784-index.htm
2019-03-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000138713119002054/0001387131-19-002054-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000138713120001765/0001387131-20-001765-index.htm
2020-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1671584/000138713120002761/0001387131-20-002761-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459018029562/0001564590-18-029562-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459018029568/0001564590-18-029568-index.htm
2018-12-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459018031354/0001564590-18-031354-index.htm
2019-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019000415/0001564590-19-000415-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1671584/000156459019008184/0001564590-19-008184-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019008190/0001564590-19-008190-index.htm
2019-04-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1671584/000156459019010940/0001564590-19-010940-index.htm
2019-04-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1671584/000156459019010941/0001564590-19-010941-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019012385/0001564590-19-012385-index.htm
2019-04-26DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1671584/000156459019013165/0001564590-19-013165-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459019017616/0001564590-19-017616-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019017641/0001564590-19-017641-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019031114/0001564590-19-031114-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459019031118/0001564590-19-031118-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459019041513/0001564590-19-041513-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459019041524/0001564590-19-041524-index.htm
2020-03-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1671584/000156459020012791/0001564590-20-012791-index.htm
2020-04-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1671584/000156459020016154/0001564590-20-016154-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459020016441/0001564590-20-016441-index.htm
2020-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1671584/000156459020017477/0001564590-20-017477-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459020025066/0001564590-20-025066-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459020027903/0001564590-20-027903-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459020040054/0001564590-20-040054-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1671584/000156459020040295/0001564590-20-040295-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1671584/000156459020041558/0001564590-20-041558-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001149/0001593968-19-001149-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001154/0001593968-19-001154-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001273/0001593968-19-001273-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001274/0001593968-19-001274-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001275/0001593968-19-001275-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001276/0001593968-19-001276-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001277/0001593968-19-001277-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001278/0001593968-19-001278-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001343/0001593968-19-001343-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001344/0001593968-19-001344-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001379/0001593968-19-001379-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001428/0001593968-19-001428-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001480/0001593968-19-001480-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001618/0001593968-19-001618-index.htm
2019-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001632/0001593968-19-001632-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001640/0001593968-19-001640-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001642/0001593968-19-001642-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001645/0001593968-19-001645-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001649/0001593968-19-001649-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001652/0001593968-19-001652-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1671584/000159396819001685/0001593968-19-001685-index.htm
2019-02-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1671584/999999999519000218/9999999995-19-000218-index.htm

Aptevo Therapeutics Inc (APVO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aptevo Therapeutics Inc (APVO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 593%
Institutional Ownership: 7518%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-10Barbara Lopez KunzBoard of DirectorsBuy10,000.000.858,481.0010,000.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001379/0001593968-19-001379-index.htm
2019-05-21Grady III GrantBoard of DirectorsBuy10,000.000.807,970.0010,000.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001154/0001593968-19-001154-index.htm
2019-07-29Fuad El-HibriBoard of DirectorsBuy55,015.000.8345,860.501,024,536.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001685/0001593968-19-001685-index.htm
2019-06-25Daniel Abdun-NabiBoard of DirectorsBuy16,667.000.9015,000.30109,351.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001480/0001593968-19-001480-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy160,000.0015.312,449,600.001,120,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-03-01Jane A GrossOfficerBuy9,138.00112,293.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000176/0001019056-19-000176-index.htm
2019-08-12Fuad El-HibriDirectorBuy100,000.000.7675,520.001,124,536.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000476/0001019056-19-000476-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy77,133.0014.221,096,831.261,197,133.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy71,241.0015.321,091,412.121,268,374.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy171,626.0023.794,082,982.541,440,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy137,241.0020.782,851,867.981,577,241.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-05KEVIN C TANG10% Share HolderBuy8,482.0020.94177,613.081,585,723.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-06KEVIN C TANG10% Share HolderBuy34,044.0020.63702,327.721,619,767.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-06KEVIN C TANG10% Share HolderBuy29,682.0022.33662,799.061,649,449.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-06KEVIN C TANG10% Share HolderBuy107,901.0023.482,533,515.481,757,350.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-06KEVIN C TANG10% Share HolderBuy2,650.0023.8763,255.501,760,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2018-12-04Marvin L WhitePresident and CEOBuy10,000.002.3823,800.00203,603.00https://www.sec.gov/Archives/edgar/data/1671584/000101905618001110/0001019056-18-001110-index.htm
2019-05-14Marvin L WhitePresident and CEOBuy10,000.000.787,800.00213,603.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000291/0001019056-19-000291-index.htm
2019-03-01Scott C StromattChief Medical Officer and SVPBuy16,269.00221,006.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000184/0001019056-19-000184-index.htm
2019-05-20Marvin L WhitePresident and CEOBuy30,000.000.8124,300.00243,603.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001149/0001593968-19-001149-index.htm
2019-06-14Marvin L WhitePresident and CEOBuy50,000.000.8844,000.00293,603.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001428/0001593968-19-001428-index.htm
2018-12-06Randy Joe MadduxSVP OperationsBuy5,000.002.3711,850.0030,000.00https://www.sec.gov/Archives/edgar/data/1671584/000101905618001118/0001019056-18-001118-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy68,296.0010.63725,986.48391,621.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy88,379.0013.111,158,648.69480,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-05-31Randy Joe MadduxSenior VP, OperationsBuy20,000.000.7314,600.0050,000.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001343/0001593968-19-001343-index.htm
2019-06-07Zsolt HarsanyiBoard of DirectorsBuy50,000.000.7839,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001344/0001593968-19-001344-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy160,000.0013.832,212,800.00640,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-03-01Michael AdelmanSVP, Commercial OperationsBuy7,318.0072,821.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000174/0001019056-19-000174-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy99,854.0013.651,363,007.10739,854.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-08-16Randy Joe MadduxSVP Operations, CMOBuy25,000.000.7619,000.0075,000.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000487/0001019056-19-000487-index.htm
2018-08-09Shawnte MitchellSVP, GC and Corporate AffairsBuy1,630.0076,135.00https://www.sec.gov/Archives/edgar/data/1671584/000101905618000956/0001019056-18-000956-index.htm
2019-03-01Jeffrey G. LamotheSVP and CFOBuy7,318.0077,194.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/0001019056-19-000178-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy60,146.0016.33982,184.18800,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-03-01Shawnte MitchellSVP, GC and Corporate AffairsBuy6,787.0082,539.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000182/0001019056-19-000182-index.htm
2019-07-10Fuad El-HibriDirectorBuy18,919.000.8516,058.45843,455.00https://www.sec.gov/Archives/edgar/data/1671584/000101905619000402/0001019056-19-000402-index.htm
2019-07-11Fuad El-HibriBoard of DirectorsBuy14,691.000.8512,453.56858,146.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001618/0001593968-19-001618-index.htm
2019-07-16Fuad El-HibriBoard of DirectorsBuy11,375.000.859,661.93869,521.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001632/0001593968-19-001632-index.htm
2019-07-17Fuad El-HibriBoard of DirectorsBuy19,136.000.8716,703.81888,657.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001640/0001593968-19-001640-index.htm
2019-07-18Fuad El-HibriBoard of DirectorsBuy14,404.000.8712,596.30903,061.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001642/0001593968-19-001642-index.htm
2019-07-19Fuad El-HibriBoard of DirectorsBuy26,460.000.9023,739.91929,521.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001645/0001593968-19-001645-index.htm
2019-07-22Fuad El-HibriBoard of DirectorsBuy30,000.000.8926,601.00959,521.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001649/0001593968-19-001649-index.htm
2020-11-04KEVIN C TANG10% Share HolderBuy160,000.0016.842,694,400.00960,000.00https://www.sec.gov/Archives/edgar/data/1671584/000120919120057304/0001209191-20-057304-index.htm
2019-07-23Fuad El-HibriBoard of DirectorsBuy10,000.000.908,996.00969,521.00https://www.sec.gov/Archives/edgar/data/1671584/000159396819001652/0001593968-19-001652-index.htm